Speaker

Jim Sahn

Co-Founder, NuvoNuro

Jim Sahn, Co-Founder at NuvoNuro, spoke at Ion Channel-Targeted Drug Development Summit (Boston, United States of America, 23–24 Sept 2026) in the session “Deep Dive Workshop: Translating Ion Channel Biology into Human Efficacy to Bridge Preclinical & Clinical Decision Making”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

Ion Channel-Targeted Drug Development Summit
23–24 Sept 2026Boston, United States of America
- WorkshopDeep Dive Workshop: Translating Ion Channel Biology into Human Efficacy to Bridge Preclinical & Clinical Decision MakingWith Theodore (Ted) Price, Gulayse Dunn

More speakers at Ion Channel-Targeted Drug Development Summit

Christopher Ahern
Professor - Molecular Physiology & Biophysics, The University of Iowa
Alejandro Amador
Vice President of R&D and Operations, Navega Therapeutics
Bruce Bean
Professor of Neurobiology, Harvard Medical School
Dan Elbaum
Chief Scientific Officer, QurAlis Corp.
Jim Ellis
Chief Scientific Officer, Nocion Therapeutics, Inc.
Kelly Gatfield
Group Leader & Scientific Leader, GlaxoSmithKline

See all 18 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jim Sahn, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].